# EDGAR Filing Document

**Accession Number:** 0000102816
**File Stem:** 0001410368-25-017063
**Filing Date:** 2025-10
**Character Count:** 19554
**Document Hash:** d8674a0ca4708f9725d3a8095de76b42
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001410368-25-017063.hdr.sgml**: 20251024

**ACCESSION NUMBER**: 0001410368-25-017063

**CONFORMED SUBMISSION TYPE**: NPORT-P

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20250831

**FILED AS OF DATE**: 20251024

**DATE AS OF CHANGE**: 20251024

**PERIOD START**: 20250831

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Eaton Vance Growth Trust
- **CENTRAL INDEX KEY:** 0000102816

**ORGANIZATION NAME:**
- **EIN:** 042325690

**FILING VALUES:**
- **FORM TYPE:** NPORT-P
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-01241
- **FILM NUMBER:** 251414375

**BUSINESS ADDRESS:**
- **STREET 1:** ONE POST OFFICE SQUARE
- **CITY:** BOSTON
- **STATE:** MA
- **ZIP:** 02109
- **BUSINESS PHONE:** 617-482-8260

**MAIL ADDRESS:**
- **STREET 1:** ONE POST OFFICE SQUARE
- **CITY:** BOSTON
- **STATE:** MA
- **ZIP:** 02109

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** EATON VANCE GROWTH TRUST
- **DATE OF NAME CHANGE:** 19930616

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** EATON VANCE GROWTH FUND INC
- **DATE OF NAME CHANGE:** 19920703

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** VANCE SANDERS COMMON STOCK FUND INC
- **DATE OF NAME CHANGE:** 19820915

## Series and Classes Contracts Data

### Eaton Vance Worldwide Health Sciences Fund (Series ID: S000005202)

| Class ID   | Class Name                                         | Ticker Symbol   |
|:---|:---|:---|
| C000014191 | Eaton Vance Worldwide Health Sciences Fund Class A | ETHSX           |
| C000014193 | Eaton Vance Worldwide Health Sciences Fund Class C | ECHSX           |
| C000014194 | Eaton Vance Worldwide Health Sciences Fund Class R | ERHSX           |
| C000081646 | Eaton Vance Worldwide Health Sciences Fund Class I | EIHSX           |

## Form NPORT-P: Monthly Portfolio Investments Report

### NPORT-P: Part A: General Information

**Item A.1. Information about the Registrant.**

- **a. Name of Registrant:** Eaton Vance Growth Trust

- **b. Investment Company Act file number:** 811-01241

- **c. CIK number of Registrant:** 0000102816

- **d. LEI of Registrant:** 549300IUJG72RXOVY252

- **e. Address and telephone number of Registrant.**

  - **Street Address 1:** One Post Office Square

  - **City:** Boston

  - **State:** MA

  - **Foreign country:** US

  - **Zip / Postal Code:** 02109

  - **Telephone number:** 617-482-8260

**Item A.2. Information about the Series.**

- **a. Name of Series:** Eaton Vance Worldwide Health Sciences Fund

- **b. EDGAR series identifier (if any):** S000005202

- **c. LEI of Series:** 549300CI26YJYCASE766

**Item A.3. Reporting period.**

- **a. Date of fiscal year-end:** 2025-08-31

- **b. Date as of which information is reported:** 2025-08-31

**Item A.4. Final filing**

Does the Fund anticipate that this will be its final filing on Form N-PORT? **No**

### Fund Information

**Total Assets:** $835711554.20

**Total Liabilities:** $1100993.90

**Net Assets:** $834610560.30

**Monthly Return Information**

| Class               | Month 1 Return (%)   | Month 2 Return (%)   | Month 3 Return (%)   |
|:---|:---|:---|:---|
| Class ID C000081646 | 0.99%                | -3.91%               | 4.93%                |
| Class ID C000014193 | 0.95%                | -4.07%               | 4.89%                |
| Class ID C000014191 | 1.03%                | -3.98%               | 4.88%                |
| Class ID C000014194 | 1.01%                | -4.00%               | 4.84%                |

**Monthly Gains & Losses**

| Period   | Net Realized Gain/Loss   | Net Unrealized Appreciation/Depreciation   |
|:---|:---|:---|
| Month 1  | $-7126440.24             | $15680334.39                               |
| Month 2  | $-5197610.42             | $-28598341.95                              |
| Month 3  | $-3983092.69             | $43237928.56                               |

### Schedule of Portfolio Investments

| Name                             | Title                                                               | Identifiers                                   | Payoff Profile   | Asset Category   | Issuer Category   | Country   |   Balance | Units   | Value (USD)   | % of Net Assets   | Maturity Date   | Coupon Type   | Annualized Rate (%)   | Restricted?   |   Fair Value Level | Lending Status   |
|:---|:---|:---|:---|:---|:---|:---|---:|:---|:---|:---|:---|:---|:---|:---|---:|:---|
| Amplifon SpA                     | Amplifon SpA                                                        | CUSIP: 000000000<br>LEI: ZYXJDNVM2JI3VBM8G556 | Long             | EC               | CORP              | IT        |    225283 | NS      | $4103080.64   | 0.49%             |  |  |  | No            |                  2 | On Loan: No      |
| Newamsterdam Pharma Co NV        | Newamsterdam Pharma Co NV                                           | CUSIP: 000000000<br>LEI: 984500B6549TF6E14D36 | Long             | EC               | CORP              | NL        |    115421 | NS      | $2775875.05   | 0.33%             |  |  |  | No            |                  1 | On Loan: No      |
| Vertex Pharmaceuticals Inc       | Vertex Pharmaceuticals Inc                                          | CUSIP: 92532F100<br>LEI: 54930015RAQRRZ5ZGJ91 | Long             | EC               | CORP              | US        |     53839 | NS      | $21052125.78  | 2.52%             |  |  |  | No            |                  1 | On Loan: No      |
| Johnson & Johnson                | Johnson & Johnson                                                   | CUSIP: 478160104<br>LEI: 549300G0CFPGEF6X2043 | Long             | EC               | CORP              | US        |    195782 | NS      | $34686696.94  | 4.16%             |  |  |  | No            |                  1 | On Loan: No      |
| UnitedHealth Group Inc           | UnitedHealth Group Inc                                              | CUSIP: 91324P102<br>LEI: 549300GHBMY8T5GXDE41 | Long             | EC               | CORP              | US        |     91226 | NS      | $28268200.62  | 3.39%             |  |  |  | No            |                  1 | On Loan: No      |
| Straumann Holding AG             | Straumann Holding AG                                                | CUSIP: 000000000<br>LEI: 50670046ML5FVIM60Z37 | Long             | EC               | CORP              | CH        |     56859 | NS      | $6662695.69   | 0.80%             |  |  |  | No            |                  2 | On Loan: No      |
| AbbVie Inc                       | AbbVie Inc                                                          | CUSIP: 00287Y109<br>LEI: FR5LCKFTG8054YNNRU85 | Long             | EC               | CORP              | US        |    262266 | NS      | $55180766.40  | 6.61%             |  |  |  | No            |                  1 | On Loan: No      |
| Thermo Fisher Scientific Inc     | Thermo Fisher Scientific Inc                                        | CUSIP: 883556102<br>LEI: HCHV7422L5HDJZCRFL38 | Long             | EC               | CORP              | US        |     36137 | NS      | $17805422.64  | 2.13%             |  |  |  | No            |                  1 | On Loan: No      |
| Cooper Cos Inc/The               | Cooper Cos Inc/The                                                  | CUSIP: 216648501<br>LEI: QJKMVPIGLH7530PCUE20 | Long             | EC               | CORP              | US        |    128221 | NS      | $8641454.30   | 1.04%             |  |  |  | No            |                  1 | On Loan: No      |
| HeartFlow Inc                    | HeartFlow Inc                                                       | CUSIP: 42238D107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    218978 | NS      | $6897807.00   | 0.83%             |  |  |  | No            |                  1 | On Loan: No      |
| Medtronic PLC                    | Medtronic PLC                                                       | CUSIP: 000000000<br>LEI: 549300GX3ZBSQWUXY261 | Long             | EC               | CORP              | IE        |    102069 | NS      | $9473023.89   | 1.14%             |  |  |  | No            |                  1 | On Loan: No      |
| Roche Holding AG                 | Roche Holding AG                                                    | CUSIP: 000000000<br>LEI: 549300U41AUUVOAAOB37 | Long             | EC               | CORP              | CH        |    127381 | NS      | $41536162.78  | 4.98%             |  |  |  | No            |                  2 | On Loan: No      |
| Zoetis Inc                       | Zoetis Inc                                                          | CUSIP: 98978V103<br>LEI: 549300HD9Q1LOC9KLJ48 | Long             | EC               | CORP              | US        |    184111 | NS      | $28794960.40  | 3.45%             |  |  |  | No            |                  1 | On Loan: No      |
| Boston Scientific Corp           | Boston Scientific Corp                                              | CUSIP: 101137107<br>LEI: Y6ZDD9FP4P8JSSJMW954 | Long             | EC               | CORP              | US        |    243280 | NS      | $25666040.00  | 3.08%             |  |  |  | No            |                  1 | On Loan: No      |
| Novo Nordisk A/S                 | Novo Nordisk A/S                                                    | CUSIP: 000000000<br>LEI: 549300DAQ1CVT6CXN342 | Long             | EC               | CORP              | DK        |    506331 | NS      | $28612466.76  | 3.43%             |  |  |  | No            |                  2 | On Loan: No      |
| Align Technology Inc             | Align Technology Inc                                                | CUSIP: 016255101<br>LEI: 549300N5YSE0U3LCP840 | Long             | EC               | CORP              | US        |     35095 | NS      | $4982086.20   | 0.60%             |  |  |  | No            |                  1 | On Loan: No      |
| Stryker Corp                     | Stryker Corp                                                        | CUSIP: 863667101<br>LEI: 5493002F0SC4JTBU5137 | Long             | EC               | CORP              | US        |     64081 | NS      | $25081944.21  | 3.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Centessa Pharmaceuticals PLC     | Centessa Pharmaceuticals PLC                                        | CUSIP: 152309100<br>LEI: 213800GIDAARDSKOI827 | Long             | EC               | CORP              | GB        |    146529 | NS      | $2460221.91   | 0.29%             |  |  |  | No            |                  1 | On Loan: No      |
| AstraZeneca PLC                  | AstraZeneca PLC                                                     | CUSIP: 000000000<br>LEI: PY6ZZQWO2IZFZC3IOL08 | Long             | EC               | CORP              | GB        |    318544 | NS      | $50780476.25  | 6.08%             |  |  |  | No            |                  2 | On Loan: No      |
| Intuitive Surgical Inc           | Intuitive Surgical Inc                                              | CUSIP: 46120E602<br>LEI: 54930052SRG011710797 | Long             | EC               | CORP              | US        |     55020 | NS      | $26040690.90  | 3.12%             |  |  |  | No            |                  1 | On Loan: No      |
| Caris Life Sciences Inc          | Caris Life Sciences Inc                                             | CUSIP: 142152107<br>LEI: 549300LX5LO78M5VPY43 | Long             | EC               | CORP              | US        |    326226 | NS      | $12523816.14  | 1.50%             |  |  |  | No            |                  1 | On Loan: No      |
| Alcon AG                         | Alcon AG                                                            | CUSIP: 000000000<br>LEI: 549300LDT5AP8S0NBM78 | Long             | EC               | CORP              | CH        |    143929 | NS      | $11470126.25  | 1.37%             |  |  |  | No            |                  2 | On Loan: No      |
| AptarGroup Inc                   | AptarGroup Inc                                                      | CUSIP: 038336103<br>LEI: VNPEQDQFAA7IY1T2PX43 | Long             | EC               | CORP              | US        |     60073 | NS      | $8366366.71   | 1.00%             |  |  |  | No            |                  1 | On Loan: No      |
| Abbott Laboratories              | Abbott Laboratories                                                 | CUSIP: 002824100<br>LEI: HQD377W2YR662HK5JX27 | Long             | EC               | CORP              | US        |    312809 | NS      | $41497241.94  | 4.97%             |  |  |  | No            |                  1 | On Loan: No      |
| Lonza Group AG                   | Lonza Group AG                                                      | CUSIP: 000000000<br>LEI: 549300EFW4H2TCZ71055 | Long             | EC               | CORP              | CH        |     25269 | NS      | $17933120.30  | 2.15%             |  |  |  | No            |                  2 | On Loan: No      |
| CSL Ltd                          | CSL Ltd                                                             | CUSIP: 000000000<br>LEI: 529900ECSECK5ZDQTE14 | Long             | EC               | CORP              | AU        |    115187 | NS      | $16023391.80  | 1.92%             |  |  |  | No            |                  2 | On Loan: No      |
| Edwards Lifesciences Corp        | Edwards Lifesciences Corp                                           | CUSIP: 28176E108<br>LEI: YA13X31F3V31L8TMPR58 | Long             | EC               | CORP              | US        |    169540 | NS      | $13790383.60  | 1.65%             |  |  |  | No            |                  1 | On Loan: No      |
| Argenx SE                        | Argenx SE                                                           | CUSIP: 04016X101<br>LEI: 7245009C5FZE6G9ODQ71 | Long             | EC               | CORP              | NL        |     17543 | NS      | $12494124.60  | 1.50%             |  |  |  | No            |                  1 | On Loan: No      |
| Morgan Stanley & Co. LLC         | Morgan Stanley Institutional Liquidity Funds - Government Portfolio | CUSIP: 61747C707<br>LEI: 549300BI6Y5SI6BYPB26 | Long             | STIV             | RF                | US        |    812863 | NS      | $812862.53    | 0.10%             |  |  |  | No            |                  1 | On Loan: No      |
| Option Care Health Inc           | Option Care Health Inc                                              | CUSIP: 68404L201<br>LEI: 549300DI3Q5ACSYJRI17 | Long             | EC               | CORP              | US        |    178995 | NS      | $5133576.60   | 0.62%             |  |  |  | No            |                  1 | On Loan: No      |
| Sanofi SA                        | Sanofi SA                                                           | CUSIP: 000000000<br>LEI: 549300E9PC51EN656011 | Long             | EC               | CORP              | FR        |    224029 | NS      | $22226353.85  | 2.66%             |  |  |  | No            |                  2 | On Loan: No      |
| Neurocrine Biosciences Inc       | Neurocrine Biosciences Inc                                          | CUSIP: 64125C109<br>LEI: 549300FECER0XBN49756 | Long             | EC               | CORP              | US        |    122298 | NS      | $17072800.80  | 2.05%             |  |  |  | No            |                  1 | On Loan: No      |
| McKesson Corp                    | McKesson Corp                                                       | CUSIP: 58155Q103<br>LEI: 549300WZWOM80UCFSF54 | Long             | EC               | CORP              | US        |     20541 | NS      | $14104272.24  | 1.69%             |  |  |  | No            |                  1 | On Loan: No      |
| Humana Inc                       | Humana Inc                                                          | CUSIP: 444859102<br>LEI: 529900YLDW34GJAO4J06 | Long             | EC               | CORP              | US        |     28499 | NS      | $8654006.34   | 1.04%             |  |  |  | No            |                  1 | On Loan: No      |
| Danaher Corp                     | Danaher Corp                                                        | CUSIP: 235851102<br>LEI: S4BKK9OTCEWQ3YHPFM11 | Long             | EC               | CORP              | US        |    100636 | NS      | $20712901.52  | 2.48%             |  |  |  | No            |                  1 | On Loan: No      |
| Mettler-Toledo International Inc | Mettler-Toledo International Inc                                    | CUSIP: 592688105<br>LEI: 5493000BD5GJNUDIUG10 | Long             | EC               | CORP              | US        |      8731 | NS      | $11359380.24  | 1.36%             |  |  |  | No            |                  1 | On Loan: No      |
| Merck & Co Inc                   | Merck & Co Inc                                                      | CUSIP: 58933Y105<br>LEI: 4YV9Y5M8S0BRK1RP0397 | Long             | EC               | CORP              | US        |    126571 | NS      | $10647152.52  | 1.28%             |  |  |  | No            |                  1 | On Loan: No      |
| Coloplast A/S                    | Coloplast A/S                                                       | CUSIP: 000000000<br>LEI: 529900NN7SOJ5QG82X67 | Long             | EC               | CORP              | DK        |     30860 | NS      | $2968622.51   | 0.36%             |  |  |  | No            |                  2 | On Loan: No      |
| Eli Lilly & Co                   | Eli Lilly & Co                                                      | CUSIP: 532457108<br>LEI: FRDRIPF3EKNDJ2CQJL29 | Long             | EC               | CORP              | US        |    115906 | NS      | $84910417.48  | 10.17%            |  |  |  | No            |                  1 | On Loan: No      |
| Royalty Pharma PLC               | Royalty Pharma PLC                                                  | CUSIP: 000000000<br>LEI: 549300FGFN7VOK8BZR03 | Long             | EC               | CORP              | GB        |    151211 | NS      | $5440571.78   | 0.65%             |  |  |  | No            |                  1 | On Loan: No      |
| IDEXX Laboratories Inc           | IDEXX Laboratories Inc                                              | CUSIP: 45168D104<br>LEI: OGMTXK0LUU1HKV2P0J84 | Long             | EC               | CORP              | US        |     25410 | NS      | $16442556.90  | 1.97%             |  |  |  | No            |                  1 | On Loan: No      |
| Bristol-Myers Squibb Co          | Bristol-Myers Squibb Co                                             | CUSIP: 110122108<br>LEI: HLYYNH7UQUORYSJQCN42 | Long             | EC               | CORP              | US        |    563654 | NS      | $26593195.72  | 3.19%             |  |  |  | No            |                  1 | On Loan: No      |
| Gilead Sciences Inc              | Gilead Sciences Inc                                                 | CUSIP: 375558103<br>LEI: 549300WTZWR07K8MNV44 | Long             | EC               | CORP              | US        |    188375 | NS      | $21280723.75  | 2.55%             |  |  |  | No            |                  1 | On Loan: No      |

### Signature

**Date Signed:** 2025-09-16

**Name of Applicant:** Eaton Vance Growth Trust

**Signature:** James Kirchner

**Name of Signer:** James Kirchner

**Title:** Treasurer